BackUnited Therapeutics Overview

United Therapeutics Current Cash

Track United Therapeutics's current cash ($1.8B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.80B
↑ 13.19% YoYΔ $210.10M vs prior year quarter

Peer trimmed avg / median

Loading

United Therapeutics Current Cash History

Loading

United Therapeutics vs. peers: Current Cash Comparison

Loading

United Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

United Therapeutics (UTHR) FAQ

As of the most recent data (June 2026), UTHR shows a current cash of $1.8B. That compares with $1.6B in the prior-year period — up 13.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, UTHR's current cash is now $1.8B (was $1.6B) — a 13.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether United Therapeutics is outperforming or lagging.

Tracking UTHR's current cash over time shows whether United Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8B That compares with $1.6B in the prior-year period — up 13.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has United Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $1.8B) with ownership activity and broader fundamentals.

United Therapeutics's current cash is $1.8B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.